1. Multidrug- and Extensively Drug-Resistant Uropathogenic Escherichia coli Clinical Strains: Phylogenetic Groups Widely Associated with Integrons Maintain High Genetic Diversity
- Author
-
Juan Xicohtencatl-Cortes, Daniela de la Rosa-Zamboni, Sara A. Ochoa, Ariadnna Cruz-Córdova, Silvia Giono-Cerezo, Briceida López-Martínez, Fernanda López-Montiel, Israel Parra-Ortega, Víctor M. Luna-Pineda, Vicenta Cázares-Domínguez, Ma. Eugenia Sepúlveda-González, Gerardo Escalona, José Arellano-Galindo, Juan Pablo Reyes-Grajeda, and Rigoberto Hernández-Castro
- Subjects
0301 basic medicine ,Microbiology (medical) ,phylogenetic groups ,030106 microbiology ,Virulence ,Drug resistance ,Integron ,medicine.disease_cause ,urologic and male genital diseases ,Microbiology ,03 medical and health sciences ,multidrug resistance ,medicine ,Pulsed-field gel electrophoresis ,Escherichia coli ,Gene ,Genetics ,biology ,Phylogenetic tree ,virulence genes ,PFGE ,bacterial infections and mycoses ,Multiple drug resistance ,biology.protein ,UPEC - Abstract
In recent years, an increase of uropathogenic Escherichia coli (UPEC) strains with Multidrug-resistant (MDR) and Extensively Drug-resistant (XDR) profiles that complicate therapy for urinary tract infections (UTIs) has been observed and has directly impacted costs and extended hospital stays. The aims of this study were to determine MDR- and XDR-UPEC clinical strains, their virulence genes and their phylogenetic groups and to ascertain their relationship with integrons and genetic diversity. From a collection of 500 UPEC clinical strains, 103 were selected with MDR [79.61% (82/103)] and XDR [20.38% (21/103)] characteristics. MDR-UPEC clinical strains were mainly associated with phylogenetic groups D (54.87%) and B2 (39.02%) with a high percentage (≥70%) of several fimbrial genes (ecpA, fimH, csgA, and papGII), an iron uptake gene (chuA), and a toxin gene (hlyA). In addition, a moderate frequency (40-70%) of other genes (iutD, tosA, and bcsA) was observed. XDR-UPEC clinical strains were predominantly associated with phylogenetic groups B2 (47.61%) and D (42.85%), which grouped with ≥80 virulence genes, including ecpA, fimH, csgA, papGII, iutD, and chuA. A moderate frequency (40-70%) of the tosA and hlyA genes was observed. The class 1 and 2 integrons that were identified in the MDR- and XDR-UPEC strains were associated with phylogenetic groups D, B2 and A, while the XDR-UPEC strains that were associated with phylogenetic groups B2, D and A showed an extended-spectrum beta-lactamase (ESBL) phenotype. The modifying enzymes (aadA1, aadB, aacC, ant1, dfrA1, dfrA17 and aadA4) that were identified in the variable region of class 1 and 2 integrons from the MDR strains showed resistance to gentamycin (56.25% and 66.66%, respectively) and trimethoprim-sulfamethoxazole (84.61% and 66.66%, respectively). The MDR- and XDR-UPEC strains were distributed into seven clusters and were closely related to phylogenic groups B2 and D. The diversity analysis by PFGE showed 42.68% of clones of MDR-UPEC and no clonal association in the XDR-UPEC clinical strains. In conclusion, phylogenetic groups including virulence genes are widely associated with two integron classes (B2 and D) in MDR- and XDR-UPEC clinical strains.
- Published
- 2016
- Full Text
- View/download PDF